This work is licensed under the Creative Commons Attribution 4.0 International License.
Weijerman ME, van Furth AM, Vonk Noordegraaf A, van Wouwe JP, Broers CJM, Gemke RJBJ. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr. Jan 2008;vol. 152, no. 1:15-19.WeijermanMEvanFurth AMVonkNoordegraaf AvanWouwe JPBroersCJMGemkeRJBJ.Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study2008vol. 152no. 1151910.1016/j.jpeds.2007.09.045Search in Google Scholar
Shin M, Besser LM, Kucik JE, Lu C, Siffel C, Correa A. Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics Dec 2009;vol. 124, no. 6:1565-1571.ShinMBesserLMKucikJELuCSi"el CCorreaA.Prevalence of Down syndrome among children and adolescents in 10 regions of the United States2009vol. 124no. 61565157110.1542/peds.2009-0745Search in Google Scholar
Wilcock DM, Griffin WST. Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J. Neuroinflammation 2013;vol. 10:84.WilcockDMGriffinWSTDown’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis2013vol. 108410.1186/1742-2094-10-84Search in Google Scholar
Weijerman ME, Broers CJM, van der Plas RN. New insights into the support of children with Down syndrome. Ned. Tijdschr. Geneeskd. 2013;vol. 157, no. 6:A5330.WeijermanMEBroersCJMvander Plas RN.New insights into the support of children with Down syndrome2013vol. 157no. 6A5330Search in Google Scholar
Hijii T, Fukushige J, Igarashi H, Takahashi N, Ueda K.Life expectancy and social adaptation in individuals with Down syndrome with and without surgery for congenital heart disease. Clin Pediatr. (Phila). Jun 1997; vol. 36, no. 6:327-332.HijiiTFukushigeJIgarashiHTakahashiNUedaKLife expectancy and social adaptation in individuals with Down syndrome with and without surgery for congenital heart disease. Clin Pediatr1997vol. 36no. 632733210.1177/000992289703600603Search in Google Scholar
Bittles AH, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol. Apr 2004;vol. 46, no. 4:282-286.BittlesAHGlassonEJClinical, social, and ethical implications of changing life expectancy in Down syndrome2004vol. 46no. 428228610.1111/j.1469-8749.2004.tb00483.xSearch in Google Scholar
Yla-Herttuala S, Luoma J, Nikkari T, Kivimaki T. Down’s syndrome and atherosclerosis. Atherosclerosis Apr 1989;vol. 76, no. 2-3:269-272.Yla-HerttualaSLuomaJNikkariTKivimakiTDown’s syndrome and atherosclerosis1989vol. 76no. 2-326927210.1016/0021-9150(89)90110-XSearch in Google Scholar
Chaney RH. Neurogenic atherosclerosis in mentally retarded persons. J Ment Defic Res. Sep 1987;vol. 31 (Pt 3):235-240.ChaneyRHNeurogenic atherosclerosis in mentally retarded persons1987vol. 31Pt 323524010.1111/j.1365-2788.1987.tb01366.x2960814Search in Google Scholar
Pueschel SM, Craig WY, Haddow JE. Lipids and lipoproteins in persons with Down’s syndrome. J Intellect Disabil Res. Aug 1992;vol. 36 (Pt 4):365-369.PueschelSMCraigWYHaddowJELipids and lipoproteins in persons with Down’s syndrome1992vol. 36Pt 436536910.1111/j.1365-2788.1992.tb00535.x1388078Search in Google Scholar
Lott IT, Head E. Alzheimer disease and Down syndrome: factors in pathogenesis. Neurobiol Aging Mar 2005;vol. 26, no. 3:383-389.LottITHeadEAlzheimer disease and Down syndrome: factors in pathogenesis2005vol. 26no. 338338910.1016/j.neurobiolaging.2004.08.00515639317Search in Google Scholar
Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer’s disease and cardiovascular disease. Mol Psychiatry Aug 2006;vol. 11, no. 8:721-736.MartinsIJHoneEFosterJKSunram-LeaSIGnjecAFullerSJNolanDGandySEMartinsRNApolipoproteinEcholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer’s disease and cardiovascular disease2006vol. 11no. 872173610.1038/sj.mp.400185416786033Search in Google Scholar
Wierzba J. Zespół Downa i medycyna : praca zbiorowa. Warszawa : Stowarzyszenie Rodzin i Opiekunów Osób z Zespołem Downa Bardziej Kochani, 2014.WierzbaJZespół Downa i medycyna : praca zbiorowa2014Search in Google Scholar
Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis. Feb 1996;vol. 3, no. 1:16-32.LemereCABlusztajnJKYamaguchiHWisniewskiTSaidoTCSelkoeDJSequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation1996vol. 3no. 1163210.1006/nbdi.1996.00039173910Search in Google Scholar
Hof PR, Bouras C, Perl DP, Sparks, DL Mehta N, Morrison JH. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down’s syndrome. Quantitative regional analysis and comparison with Alzheimer’s disease. Arch Neurol. Apr 1995;vol. 52, no. 4:379-391.HofPRBourasCPerlDPSparksDLMehtaNMorrisonJH.Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down’s syndrome1995vol. 52no. 437939110.1001/archneur.1995.005402800650207710374Search in Google Scholar
Rocca WA, Amaducci LA, Schoenberg BS Epidemiology of clinically diagnosed Alzheimer’s disease. Ann Neurol. May 1986;vol. 19, no. 5:415-424.RoccaWAAmaducciLASchoenbergBS Epidemiology of clinically diagnosed Alzheimer’s disease.Ann Neurol1986vol. 19no. 541542410.1002/ana.4101905023717905Search in Google Scholar
Mayeux R, Honig LS, Tang M-X, Manly J, Stern Y, Schupf N, Mehta PD. Plasma A[beta]40 and A[beta]42 and Alzheimer’s disease: relation to age, mortality, and risk. Neurology Nov 2003; vol. 61, no. 9:1185-1190.MayeuxRHonigLSTangM-XManlyJSternYSchupfNMehtaPDPlasma A[beta]40 and A[beta]42 and Alzheimer’s disease: relation to age, mortality, and risk2003vol. 61no. 91185119010.1212/01.WNL.0000091890.32140.8F14610118Search in Google Scholar
Bates KA, Sohrabi HR, Rodrigues M, Beilby J, Dhaliwal SS, Taddei K, Criddle A et al. Association of cardiovascular factors and Alzheimer’s disease plasma amyloid-beta protein in subjective memory complainers. J Alzheimer Dis. 2009;vol. 17, no. 2:305-318.BatesKASohrabiHRRodriguesMBeilbyJDhaliwalSSTaddeiKCriddleAet alAssociation of cardiovascular factors and Alzheimer’s disease plasma amyloid-beta protein in subjective memory complainers2009vol. 17no. 230531810.3233/JAD-2009-105019363264Search in Google Scholar
Ward MA, Carlsson CM, Trivedi MA, Sager MA, Johnson SC. The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol. Dec 2005; vol. 5:23.WardMACarlssonCMTrivediMASagerMAJohnsonSCThe effect of body mass index on global brain volume in middle-aged adults: a cross sectional study2005vol. 52310.1186/1471-2377-5-23132525416321166Search in Google Scholar
Kramer AF, Erickson KI, Colcombe SJ. Exercise, cognition, and the aging brain. J Appl Physiol. Oct 2006;vol. 101, no. 4-1237-1242.KramerAFEricksonKIColcombeSJExercise, cognition, and the aging brain2006vol. 101no. 4-1237-124210.1152/japplphysiol.00500.200616778001Search in Google Scholar
Barzilai N, Atzmon G, Derby CA, Bauman JM, Lipton RB. A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology Dec 2006;vol. 67, no. 12:2170-2175.BarzilaiNAtzmonGDerbyCABaumanJMLiptonRBA genotype of exceptional longevity is associated with preservation of cognitive function2006vol. 67no. 122170217510.1212/01.wnl.0000249116.50854.6517190939Search in Google Scholar
McGrowder D, Riley C, Morrison EYSA, Gordon L. The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol 2011;vol. 2011;496925.McGrowderDRileyCMorrisonEYSAGordonLThe role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer2011vol. 201149692510.1155/2011/496925306589521490772Search in Google Scholar
Kontush A, Chapman MJ. HDL: close to our memories? Arteriosclerosis, thrombosis, and vascular biology. Aug 2008;vol. 28, no. 8. United States:1418-1420.KontushAChapmanMJHDL: close to our memories? Arteriosclerosis, thrombosis, and vascular biology2008vol. 28no. 8United States:1418-142010.1161/ATVBAHA.108.16971418650505Search in Google Scholar
Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, Jain S. et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest. Feb 2008;vol. 118, no. 2:671-682.WahrleSEJiangHParsadanianMKimJLiAKnotenAJainS.et alOverexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease2008vol. 118no. 267168210.1172/JCI33622Search in Google Scholar
Olesen OF, Dago L. High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Commun. Apr 2000;vol. 270, no. 1:62-66.OlesenOFDagoLHigh density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils2000vol. 270no. 1626610.1006/bbrc.2000.2372Search in Google Scholar
Hardy J, Cullen K. Amyloid at the blood vessel wall. Nature medicine, Jul 2006;vol. 12, no. 7. United States:756-757.HardyJCullenKAmyloid at the blood vessel wall2006vol. 12no. 7United States:756-75710.1038/nm0706-756Search in Google Scholar
Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol. Aug 2008;vol. 28, no. 8:1556-1562.Singh-ManouxAGimenoDKivimakiMBrunnerEMarmotMG.Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study2008vol. 28no. 81556156210.1161/ATVBAHA.108.163998Search in Google Scholar
Reitz C, Tang M-X, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol. May 2004;vol. 61, no. 5:705-714.ReitzCTangM-XLuchsingerJMayeuxRRelation of plasma lipids to Alzheimer disease and vascular dementia2004vol. 61no. 570571410.1001/archneur.61.5.705Search in Google Scholar
Solomon A, Kareholt I, Ngandu T, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M. Serum cholesterol changes a*er midlife and late-life cognition: twenty-one-year follow-up study. Neurology, Mar 2007;vol. 68, no. 10:751-756.SolomonAKareholtINganduTWinbladBNissinenATuomilehtoJSoininenHKivipeltoMSerum cholesterol changes a*er midlife and late-life cognition: twenty-one-year follow-up study2007vol. 68no. 1075175610.1212/01.wnl.0000256368.57375.b7Search in Google Scholar
Sparks DL, HunsakerJC3rd, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR. Cortical senile plaques in coronary artery disease, aging and Alzheimer’s disease. Neurobiol Aging, 1990;vol. 11, no. 6:601-607.SparksDLHunsakerJC3rdScheffSWKryscioRJHensonJLMarkesberyWR.Cortical senile plaques in coronary artery disease, aging and Alzheimer’s disease1990vol. 11no. 660160710.1016/0197-4580(90)90024-TSearch in Google Scholar
Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. Feb 2003;vol. 27, no. 2:260-268.EliasMFEliasPKSullivanLMWolfPAD’AgostinoRB.Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study2003vol. 27no. 226026810.1038/sj.ijo.80222512587008Search in Google Scholar
Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. Oct 2001;vol. 154, no. 7:635-641.LuchsingerJATangMXSternYSheaSMayeuxRDiabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort2001vol. 154no. 763564110.1093/aje/154.7.63511581097Search in Google Scholar
Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurology, Feb 2005;vol. 64, no. 3:494-500.HonigLSKukullWMayeuxRAtherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center2005vol. 64no. 349450010.1212/01.WNL.0000150886.50187.3015699381Search in Google Scholar
Murdoch JC, Rodger JC, Rao SS, Fletcher CD, Dunnigan MG. Down’s syndrome: an atheroma-free model? Br Med J. Jul 1977;vol. 2, no. 6081:226-228.MurdochJCRodgerJCRaoSSFletcherCDDunniganMGDown’s syndrome: an atheroma-free model? Br Med J1977vol. 2no. 608122622810.1136/bmj.2.6081.226Search in Google Scholar
Brattstrom L, Englund E, Brun A. Does Down syndrome support homocysteine theory of arteriosclerosis? Lancet (London, England), Feb 1987;vol. 1, no. 8529. ENGLAND:391-392.BrattstromLEnglundEBrunADoes Down syndrome support homocysteine theory of arteriosclerosis?1987vol. 1no. 8529ENGLAND:391-39210.1016/S0140-6736(87)91772-7Search in Google Scholar
Hill DA, Gridley G, Cnattingius S, Mellemkjaer L, Linet M, Adami H-O, Olsen JH, Nyren O, Fraumeni JFJ. “Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med. Mar 2003;vol. 163, no. 6:705-711.HillDAGridleyGCnattingiusSMellemkjaerLLinetMAdamiH-OOlsenJHNyrenOFraumeniJFJ.“Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med2003vol. 163no. 670571110.1001/archinte.163.6.705Search in Google Scholar
Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol. Mar 2005;vol. 47, no. 3:171-176.DaySMStraussDJShavelleRMReynoldsRJMortality and causes of death in persons with Down syndrome in California2005vol. 47no. 317117610.1017/S0012162205000319Search in Google Scholar
Dorner K, Gaethke AS, Tolksdorf M, Schumann KP, Gustmann H. Cholesterol fractions and triglycerides in children and adults with Down’s syndrome. Clin Chim Acta. Oct 1984;vol. 142, no. 3:307-311.DornerKGaethkeASTolksdorfMSchumannKPGustmannHCholesterol fractions and triglycerides in children and adults with Down’s syndrome1984vol. 142no. 330731110.1016/0009-8981(84)90267-5Search in Google Scholar
Salo MK, Solakivi-Jaakkola T, Kivimaki T, Nikkari T. Plasma lipids and lipoproteins in Down’s syndrome. Scand J Clin Lab Invest. Sep 1979;vol. 39, no. 5:485-490.SaloMKSolakivi-JaakkolaTKivimakiTNikkariTPlasma lipids and lipoproteins in Down’s syndrome1979vol. 39no. 548549010.3109/00365517909106135Search in Google Scholar
Zamorano A, Guzman M, Aspillaga M, Avendano A, Gatica M. Concentrations of serum lipids in children with Down’s syndrome. Arch Biol Med Exp. (Santiago). 1991;vol. 24, no. 1:49-55.ZamoranoAGuzmanMAspillagaMAvendanoAGaticaMConcentrations of serum lipids in children with Down’s syndrome1991vol. 24no. 14955Search in Google Scholar
Adelekan T, Magge S, Shults J, Stallings V, Stettler N. Lipid profiles of children with Down syndrome compared with their siblings. Pediatrics, Jun 2012;vol. 129, no. 6:e1382-1387.AdelekanTMaggeSShultsJStallingsVStettlerNLipid profiles of children with Down syndrome compared with their siblings2012vol. 129no. 6e1382138710.1542/peds.2011-1262Search in Google Scholar
Bocconi L, Nava S, Fogliani R, Nicolini U. Trisomy 21 is associated with hypercholesterolemia during intrauterine life. Am J Obstet Gynecol., Mar 1997;vol. 176, no. 3:540-543.BocconiLNavaSFoglianiRNicoliniUTrisomy 21 is associated with hypercholesterolemia during intrauterine life1997vol. 176no. 354054310.1016/S0002-9378(97)70544-1Search in Google Scholar